Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria chemoprevention drug resistance survey in infants from Koutiala, Mali
PACTR202401827533382Completed
- Sponsor
- AAS Biotech
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sulfadoxine + pyrimethamine and amodiaquine in malaria (2 arms), sponsored by AAS Biotech. Started Jan 2022; status: completed.
02
Drugs
sulfadoxine + pyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202401827533382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401827533382.